AZTherapies is a biopharmaceutical company developing novel small molecules and biologic therapies that aim to fundamentally change neurodegenerative disease progression, extending normal cognition and function and improving quality of life in the aging population.

Register for Details

For more details on financing and valuation for AZTherapies, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about AZTherapies

Forge green plus iconForge green minus icon

What is AZTherapies's funding to date?

AZTherapies has raised $121.38MM to date.
Forge green plus iconForge green minus icon

When was AZTherapies founded?

AZTherapies was founded in 2011.

AZTherapies Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
8/28/2020 Series C-1 $35MM raised $XXX.XX $XXX.XX
10/7/2019 Series C $37.5MM raised $XXX.XX $XXX.XX
6/18/2018 Series B $18.98MM raised $XXX.XX $XXX.XX
11/20/2015 Series A and A-2 $22.96MM raised $XXX.XX $XXX.XX
12/22/2014 Series A-1 $6.93MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Apr 19, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.